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Microcirculation is the terminal vascular network where the exchange of substances between
the blood and the tissues occurs. Usually, the term refers to functional unit comprising vessels
with a diameter of less than 100 μm, including arterioles, capillaries, and venules. Appropriate
vascularization of tissues and an intact microcirculatory bed are prerequisites for adequate
tissue perfusion and thus normal organ functioning. The unique feature of microcirculation is
its large area which in conjunction with low velocity of blood flow enables appropriate
conditions for the exchange of substances between the blood and the tissues. Another impor‐
tant issue is its adaptability either to acute changes of organ demands or to chronic changes in
its environment. These tasks are primarily accomplished by arterioles as the main targets and
effectors of vascular tone regulation including the vascular endothelium and smooth muscle
cells, as well as adjacent cells and humoral and nervous factors all playing in a fine orchestrated
concert. The principal characteristics of fluid and substances trafficking across the capillary
wall according to classical Fick and Starling principles and depending on the concentration
gradients of substances transported, on capillary permeability, and on hydrostatic and oncotic
pressures are described elsewhere.
1. Structural and functional organization: some general and special features
The  structural  organization  of  the  microcirculation  is  tightly  coupled  to  its  physiologic
function.  As organs serve different functions and have different metabolic demands,  the
microcirculatory networks differ among organs. The complexity and heterogeneity in blood
flow and metabolism in respect to one tissue as well as in different tissues have been confirmed
in animal experiments and in patients due to advanced imaging techniques.
The book starts with a comprehensive overview of the coronary microcirculation written by
Fonseca et al., thoroughly describing the characteristics of coronary microcirculation, from
anatomical and histological aspects to physiology with emphasis on the regulatory mecha‐
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nisms, and finally elucidating some pathophysiologic mechanisms in relation to systemic
cardiovascular diseases. Of interest is the impact of perycites to the regulation of microcircu‐
lation as pointed out in the chapter, as well as a rather neglected field of venous part of the
microcirculation [1]. The chapter specially focuses on the regulation of coronary microvascu‐
lature with the presentation of all known mechanisms that might be applied also to other
vascular beds, i.e., the myogenic control, the endothelial component, and the metabolic
regulation [2]. The latter presumably plays the most important role in the coronary microcir‐
culation due to constantly changing demands of the working heart muscle [3]. Additionally,
systemic factors such as the autonomic nervous system and humoral mediators are elucidated.
As diseases of the cardiovascular system nowadays represent the leading cause of morbidity
and mortality all over the world, the most frequent pathologies of the coronary vessels are
presented [4]. The heart vessels are very prone to structural remodeling, vascular rarefaction,
and perivascular fibrosis finally culminating in luminal obstruction what might be detrimental
for the patient; apart from macrocirculation, it is the microcirculation that is suggested to play
a key role in the coronary pathophysiology [5]. The impact of risk factors, oxidative stress and
inflammation, and the interplay between various regulatory mechanisms, all predisposing to
heart disease development are comprehensively exposed with a brief link to some metabolic
diseases.
The dependence of the cellular metabolism on tissue blood flow and vice versa is more
extensively described in the following chapter written by Kolka, which focuses on the
microcirculation of skeletal muscle and also proposes some therapeutic interventions in
targeting the skeletal muscle microcirculation to treat both vascular and metabolic diseases.
The skeletal muscle microcirculation is subjected to the greatest variations of blood flow and
nutrients breakdown during strenuous exercise as compared to resting conditions. During
resting conditions, only about 20% of capillaries are perfused: the blood flow is estimated to
amount 5–10 mL/min/100 g, compared up to 80–100 mL/min/100 g during exercise [6], pointing
to complex mechanisms of blood flow regulation. Worth to mention is the difficulty to estimate
these changes and microvascular dynamics at the capillary level with the available techniques.
In the chapter, an interesting scientific approach for the evaluation of substrate exchange in
the microenvironment of skeletal muscle is presented, namely, the lymph sampling [7, 8].
Taking into account great variations in the metabolic rate as well as the type and rate of
substrates metabolized regarding intensity and mode of exercise, it is compelling to speculate
that changes in blood flow will affect metabolism. In this respect, vasoactive compounds
affecting vascular tone and perfusion could also indirectly affect the metabolism. Insufficient
perfusion might in turn lead to deranged metabolic pathways making one more susceptible
to metabolic diseases, such as diabetes and obesity [9]. Interestingly, nitric oxide (NO) as a key
endothelial vasodilator also directly affects metabolism by competing with mitochondria for
oxygen and consequently inhibiting the oxidative phosphorylation and potentially switching
the metabolism to some other (anaerobic) pathways [10]. Apart from classical vasoactive
substances mainly released from the endothelium, many hormones are themselves vasoactive;
glucagon‐like peptide has been shown to increase capillary perfusion on acute basis and
angiogenesis on longer term, and considering this, might represent a potential therapeutic
target [11, 12]. In addition, some important interactions among vasoactive compounds and
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hormones have been elucidated in the chapter, such as the interference of angiotensin II (Ang)
and NO systems [8], and the prevention of endothelin‐induced vasoconstriction by insulin and
adiponectin [13, 14]. Insulin also directly affects capillary recruitment and at supraphysiologic
concentrations, it has been shown to increase blood flow in human skeletal muscles and skin
[15]. Capillary density has been directly correlated with insulin sensitivity thus strengthening
the hypothesis that capillary recruitment importantly contributes to insulin‐mediated glucose
uptake [16]. As exposed in the chapter of Kolka, an important question to be resolved is the
process of insulin trafficking across the endothelial barrier. At this place, a word should be
devoted to endothelial glycocalix, which presents an additional structural and functional
endothelial barrier that in turn affects the composition of the muscle interstitium and conse‐
quently the supply of nutrients to the cells. Glycocalix has thoroughly been investigated as a
potential therapeutic target [17].
2. The central role of endothelium in the regulation of vascular tone
Although endothelium also plays an important role in the processes of inflammation, hemo‐
stasis, and tissue repair, its prominent role in the physiological regulation of vascular tone
along with a vast number of endothelial vasoactive substances and their interactions are most
extensively exposed in the book. Accordingly, all endothelial mediators might represent a
potential therapeutic target as briefly pointed out in some chapters.
The importance of functionally intact endothelium is already obvious in the newborn as ex‐
posed in the chapter of Wright and Dyson. Apart from the involvement of the autonomic
nervous system and the sympathoadrenal activation at birth, substances released from en‐
dothelium importantly contribute to the delicate balance between vasodilators and vasocon‐
strictors which is a prerequisite for normal circulatory function. To list just a few,
isoprostanes and prostaglandins released in response to increased partial oxygen pressure
at birth play a major role in the closure of ductus arteriosus, thus enabling the transition to
the adult‐type circulation taking place at birth [18]. In preterm infants, this delicate balance
is disturbed in terms of enhanced vasodilation and diminished vasoconstriction rendering
them more susceptible to hypotension resulting in organ hypoperfusion and potentially ir‐
reversible end‐organ damage [19]. An interesting feature pointed out in the chapter is great‐
er susceptibility of male preterm newborns to developing potentially fatal hypotension,
which has been speculated to be due to increased levels of gaseous neurotransmitter hydro‐
gen sulfide (H2S) in males [20]. Accordingly, the assessment of urinary concentrations of thi‐
osulfate, a metabolite of H2S [20, 21] and normetanephrine, a measure of total body
sympathoadrenal activity [22], respectively, might predict the outcome. The impact of other
gaseous compounds is additionally described in the chapter, with the leading role of NO,
presumably involved in the regulation of basal vascular tone, and carbon monoxide (CO),
apparently playing a crucial regulatory role in the cerebral circulation during the transition
period [23, 24]. While most observations were deduced from animal studies or isolated
models, far more complex interplay takes part in humans in vivo. A lot of potential cross‐
talks and the influence of one mediator on the other one could merely be speculated, as ex‐
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posed in the chapter [23]. Their potential adaptive role and their impact in the neonatal
period are emphasized. Of interest, the interplay of NO, CO, and H2S differ in neonates and
in the adults, which in addition to the chapter of Wright and Dyson is also exposed in the
chapter of Fonseca et al. [25].
The role of NO as a key endothelial vasodilator has briefly been corroborated in the chapters
of Fonseca et al., Zupan, and Schier et al. Yet, other vasodilators presumably are even more
important at the level of microcirculation, the central role being played by the metabolites of
arachidonic acid (AA), extensively exposed in the chapter of Drenjančević et al. Three impor‐
tant pathways of AA metabolism are presented, including: the cyclooxygenase (COX) pathway,
the lipopxygenase (LOX) pathway, and the cytochrome (CYP) pathway. In the chapter, the
mostly investigated products of these metabolic pathways and their potential interactions at
the level of the vascular smooth muscle are thoroughly presented. Worth to emphasize is the
dual role of the above‐mentioned enzymes, namely, they catalyze the production of vasocon‐
strictors as well as vasodilators and it is their delicate balance that finally determines the proper
vascular tone. In many diseases, this fine balance is disturbed, such as in obesity, diabetes,
hypertension, and other metabolic and cardiovascular diseases. Of the CYP metabolites of AA,
epoxyeicosatrienoic acids (EETs) have been implicated as endothelium‐derived hyperpolariz‐
ing factors (EDHF), contributing to proper vasodilation in the settings with reduced bioavail‐
ability of NO [26], such as in increased production of reactive oxygen species (ROS), which
uncouple the endothelial nitric oxide synthase (eNOS), and consequently augment additional
release of ROS from eNOS itself.
An interesting aspect is the nonenzymatic metabolism of AA, mainly mediated by ROS which
nowadays are widely recognized as mediators of cellular immunity, inflammation, and tissue
repair, and also indirectly affect vascular tone [27]. The impact of ROS as potential (noxious)
vascular messengers is also dealt with in some other chapters.
Additional interesting suggestion presented in the chapter of Drenjančević et al is potentially
positive contribution of Ang, which has usually been presented as a foe in the vascular
homeostasis. Contrary to the common accepted knowledge, they propose that sufficient levels
of Ang actually are essential for normal vascular function, as confirmed in the studies which
have demonstrated that a decrease in the circulating levels of Ang lead to impaired microvas‐
cular endothelial function [28]. As for Ang, Kolka additionally exposes its effect on blood vessel
permeability which indirectly also affects the tissue metabolism [29].
Yet, the effects of endothelial vasoactive compounds are not that straightforward, as there are
many interactions depending also on the vascular bed studied and being also tissue and species
specific.
The deranged interplay of endothelial mediators in the pathogenesis of various diseases of
modern era has long been implicated. As stated in the subsequent subheading, some chap‐
ters address the question of endothelial dysfunction as a hallmark of many diseases. More‐
over, the dysfunction of endothelium often precedes the clinical manifestation of the
disease.
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3. Dysfunctional microcirculation is a hallmark of many diseases
The importance of intact and functional microcirculation with preserved adaptability to meet
organ metabolic demands has long been appreciated. It has been confirmed in many inde‐
pendent studies that deranged microcirculation compromises normal organ function and
finally the organism as a whole. Either deranged vascular control in terms of deranged
autonomic nervous system as pointed out in the research chapter of Malan et al. as well as in
terms of endothelial dysfunction have been implicated. Increased sympathetic tone or
disturbed responsivity to adrenergic challenges might induce increased vasoconstrictor tone
finally leading to hypertension and inappropriate structural remodeling of the vessel wall.
Endothelial vasoconstrictors and increased oxidative stress also augment the vasoconstrictor
component causing ischemia and tissue failure on a larger time scale. Microvascular dysfunc‐
tion has been shown to be the primary event in the pathogenesis of many metabolic and
cardiovascular pathologies which is shortly mentioned in other chapters. On the other hand,
injury and inflammation subsequently trigger angiogenesis and structural adaptation that
have the potential of restitution, which takes part after say surgical procedures as pointed out
in the chapter of Schier et al. The potential to restitute ad integrum strongly depends on the
preoperative state of the microcirculation and on other known vascular risk factors such as
hypertension, smoking, diabetes, obesity, etc. [30]. Potential risk factors can partly be overcome
by changes in lifestyle and some interventions such as exercise. Moreover, the letter may
strongly affect the outcome of a therapeutic procedure as stressed in the chapter of Schier et
al. [31].
A good model of microvascular dysfunction potentially leading to impairment of the central
nervous system and causing high mortality and morbidity is leukoaraiosis. The term, poten‐
tially unfamiliar to broader medical public, denotes diffuse confluent changes in the cerebral
white matter often accidentally detected on neuroradiological imaging. Its prevalence in the
population aged between 50 and 75 years has been estimated to comprise up to 25% and, as
such, undoubtedly must be regarded as highly clinical significant in terms of predisposing to
various degrees of cognitive impairment, ischemic events, and stroke [32]. In his chapter,
Zupan thoroughly describes the pathogenesis of leukoaraiosis, which includes a spectrum of
factors, often apparently discordant, ranging from endothelial dysfunction to leaky blood‐
brain barrier on one side [33], to ischemia on the other [34], yet all causing chronic perfusion
impairment. Similar factors and causes could actually be applied also to other microcirculatory
networks. In his chapter, Zupan reports that the prevalence of leukoaraiosis is higher in the
Blacks than in the Whites. This might be connected to increased prevalence of hypertension in
the Blacks which has extensively been discussed also in the chapter of Malan et al. [35].
Interestingly, Malan et al. also showed a close link between depressive disorders and vascular
dysfunction of the retinal artery in terms of sympathoadrenal disbalance. The correlation was
significantly more pronounced in the Blacks compared to the Whites pointing out an important
role of ethical predisposition and genetic susceptibility on one side, but also risk factors on the
other side [36]. Interestingly, chronic depression has been related to attenuated cortisol levels
which would impact the synthesis of epinephrine [37], as proposed in the chapter of Malan et
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al. All these facts must be taken into account when designing the therapeutic strategies and a
proper follow‐up of patients.
Another interesting aspect of endothelial dysfunction addressed in the chapter of Drenjančecić
et al. is the impact of high salt diet on vascular function [38]; vascular pathologies linked to
increased salt intake undoubtedly represent a great burden of the civilized world. As already
stated, other aspects of endothelial dysfunction are extensively presented also in the chapters
of Fonseca et al. with emphasis on the involvement of coronary microcirculation in the
pathogenesis of cardiovascular events, and in the chapter of Kolka on skeletal muscle micro‐
circulation and its involvement in metabolic (obesity, diabetes) and cardiovascular diseases
(hypertension).
While those chapters mainly deal with mechanisms of endothelial dysfunction, more clinical
aspects in terms of the determination of microvascular and endothelial dysfunction are
illustrated in the chapters of Tamas‐Szora et al. and Todea et al. They present some potential
diagnostic tools for an early detection of microvascular dysfunction as well as for tracing the
outcome and the evaluation of the effectiveness of treatment.
4. In vivo applicability of some methods for clinical evaluation of
microcirculation
Modern techniques with relatively high spatial resolution have enabled a timely detection of
the disease, which is a prerequisite for an adequate treatment. Within the noninvasive imaging,
sound‐ and light‐based imaging techniques are able to provide high resolution and clinically
relevant information in assessing microcirculation.
Mostly applied optical imaging techniques for clinical evaluation of the microcirculation today
include (dynamic) capillaroscopy, confocal microscopy, two photon imaging, and stimulated
emission depletion microscopy for tracing superficial structures; optical coherence tomogra‐
phy, hyperspectral imaging, side stream dark field imaging, and incident dark field imaging
for assessing subsuperficial microvascular beds; and diffusion correlation spectroscopy,
functional near infrared spectroscopy, and photoacoustic tomography to assess deeper
structures [39]. Obviously, each technique is designed for determination of special microcir‐
culation network and its position regarding the depth of a tissue.
In spite of many methods available, in the book, only two noninvasive techniques are exten‐
sively presented, namely, the contrast enhanced ultra‐sonography (CEUS) and the laser
Doppler (LD) fluxmetry (LDF) in the chapters of Tamas‐Szora et al. and Todea et al., respec‐
tively. Their applicability in the assessment of vascular dearrangement in tumor evolvement,
angiogenesis, inflammation, and some other pathologies and in the assessment of dental
pathologies, respectively, is presented along with some advantages and disadvantage of both.
Both methods are based on optical and acoustic penetration of a tissue and exploit the Doppler
effect causing the frequency shift of illuminated light and sound, respectively, due to reflections
from moving particles, i.e., predominantly erythrocytes. Both chapters give insight into
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potential clinical applicability of CEUS and LDF for tracing microcirculation and emphasize
the need and importance of performing in vivo studies on humans.
In their chapter, Tamas‐Szora et al. comprehensively describe the principles governing CEUS
as well as some modifications and their various applicability, substantiated with representing
illustrative figures that accompany the text and enable a better perception of the method for
unfamiliar readers. CEUS has rendered itself a valuable clinical tool for assessing vasculari‐
zation in various tissues, specially parenchymal organs, such as liver [40], testicles, kidney [41],
and mammary glands [42]. Yet, the limitation inherent to all sonographic methods described
so far is that CEUS enables the discrimination of the vessels of size of around 100 μm and, in
this respect, does not accurately evaluate the proper “microcirculation” [43]. Nevertheless, it
is highly applicable in the clinical settings as it enables the detection of blood flow down to
velocities less than 2 cm/s, and the discrimination between inflammatory and degenerative
pathology as in musculoskeletal diseases [44]. In this regard, capillary perfusion could be
indirectly estimated, i.e., either increased perfusion in say inflammation or cessation of blood
flow in ischemic tissues.
To improve the CEUS technique, different contrasting agents that augment the signals under
observation might be applied; yet, they increase the diagnostic costs. The advantages of CEUS
over some other methods include repeatability, lack of harmful effects as in computer tomog‐
raphy (CT) caused by ionizing radiation, and high spatial and temporal resolution to list just
a few. Target‐specific structures might additionally be detected by combining the contrast
agent with specific antibodies.
LDF and its update, LD imaging [45] with its varieties remain the gold standard for clinical
evaluation of microcirculation as described in the chapter of Todea et al. In the chapter, some
results of authors’ own experiments evaluating the outcome of therapy in terms of microvac‐
sular function are exposed. LDF has proven to be an effective tool of choice to evaluate
microcirculation in the oral cavity, preferentially of the gingiva and dental pulp, respectively
[46, 47]. LD techniques enable assessment of tooth vitality after various procedures including
bleaching, tooth implants and prepared teeth, surgical intervention after trauma, as well as
tracing microcirculation following treatment of gingival disease, such as inflammation, and
gingival blood flow resolution after surgical procedures. Supposedly, LDF also enables to
evaluate the redistribution of blood flow through arteriovenous anastomoses that are a unique
feature of the cutaneous and mucous microcirculation.
5. Therapeutic interventions at the level of microcirculation: potential
role of endothelial progenitor cells (EPCs)
Interventional studies have focused on various aspects of microvascular function, as already
outlined in the chapters of Fonseca et al., Kolka, Drenjančević et al., and Zupan. Many
vasoactive compounds might represent therapeutic targets, either by targeting their endothe‐
lial receptors or interfering with their synthesis by acting on the corresponding intracellular
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enzymes. In addition, interfering with the renin‐angiotensin‐aldosterone [48] system seems a
promising therapeutical intervention to treat vascular and associated metabolic diseases as
pointed out in the chapter of Kolka. The effects of phosphodiesterase inhibitors (Sildenafil and
Tadalafil), and thiazolidinediones on vascular function, capillary recruitment, and conse‐
quently metabolism have also been investigated, as exposed by Kolka. The potential interven‐
tion on the level of glycocalyx has already been mentioned [17]. An interesting target affecting
the metabolism of fat and increasing energy expenditure and angiogenesis might be brown
adipose tissue, as briefly exposed in the chapter of Kolka [49]. Moreover, the supplementation
of L‐arginine might ameliorate vascular complications in patients suffering from neurodege‐
nerative and vascular diseases as mentioned in the chapter of Zupan [50].
Apart from the above‐mentioned targets, endothelial progenitor cells have evolved over the
last few years as a promising new strategy for targeting microvascular and subsequently
organ dysfunction. Nowadays, many studies are being conducted on how the injection of
EPCs on the site of injury or damaged organ affects potential improvement of organ func‐
tion. Apart from acute adjustments, chronic adjustments in terms of increased angiogenesis
are crucial for tissue regeneration. Angiogenesis and vasculogenesis are key events in di‐
recting proper organ function, not only during fetal life, but also later in adulthood. EPCs
also play an important role in vascularization in pregnancy [51]. They are important com‐
ponent in tissue regeneration and, in this respect, might represent a potential therapeutic
niche. Thus, improvements of techniques to obtain sufficient number of EPCs from the pe‐
ripheral circulation, or from the bone marrow, proper harvesting and breeding are prereq‐
uisites for efficient therapy. Some important aspects of EPCs are presented in the chapter of
Nova‐Lamperti et al., where the crucial technical steps in obtaining and manipulating the
cells are presented as well as the results of some studies investigating the effects of therapy
with EPCs. Furthermore, the stimuli for migration, recruitment, and differentiation of stem
cells affecting angiogenesis in vivo are corroborated. Unfortunately, the potential of EPCs
for proper angiogenesis strongly depends on the clinical condition and risk factors of the
individuum. Namely, it has been shown that the number of EPCs conversely correlated
with cardiovascular risk factors, such as hypercholesterolemia, hypertension, smoking, dia‐
betes mellitus, and dyslipidemia. Moreover, lower numbers of EPCs as compared to
healthy ones have been shown in patients suffering from unstable angina, myocardial in‐
farction, as well as atherosclerosis, and erectile dysfunction, as described in the chapters of
Schier et al. and Nova‐Lamperti et al. On the other hand, some cytokines, hormones, drugs,
and physical activity increase the number and function of EPCs. In this respect, the impor‐
tance of physical activity could not be overemphasized. Some good and positive examples
are presented in the chapter of Schier et al. who have shown that even short lasting sub‐
maximal exercise performed preoperatively to assess the cardiopulmonary status of a pa‐
tient might significantly improve the outcome after major surgery in patients [31, 52]. In
this respect, regular exercise should be strongly encouraged in all groups of patients, let
alone in healthy populations in general practice. Clinical applicability of EPCs has already
been confirmed in many clinical trials, when ex vivo expanded EPCs were injected into the
damaged area of tissue, such as in the treatment of acute myocardial infarction [53], in the
recovery from deep venous thrombosis, in the recanalization of organized venous thrombi
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[54], in pulmonary arterial hypertension [55], in attenuation of peripheral artery disease
[56], and in liver regeneration [57]. Yet, the disadvantage of such therapy is a very low
number of EPCs in peripheral blood and relatively high costs of mobilization. Nevertheless,
EPCs seem to represent a promising future therapeutic approach for the treatment of “mod-
ern era” diseases.
6. Conclusion
In the introductory chapter, I intended to briefly sum up the content of the book, exposing
some interesting features of separate chapters. Basic principles of the microvascular blood
flow and vascular tone regulation are briefly presented with endothelium playing a central
role. Today, researchers are focused on complex interactions of vasoactive compounds trying
to elucidate their potential interplays in health and disease, which would accomplish thera-
peutic strategies. Prototypes of alternative therapeutic approach presented in the book
might be exercise as a type of self-governed therapy on one side, and EPCs as a kind of com-
plex hospital-based therapy. As diseases of the cardiovascular system are the leading cause
of morbidity and mortality in modern world, additional efforts in establishing new diagnos-
tic tools and efficient therapies are urgently needed. The authors have provided comprehen-
sive overviews and opened up new challenging questions that I hope would be useful to
scientists involved in the microcirculation which remains an unlimited field of inspiration. A
lot has already been unrevealed, and the rest is yet to be discovered.
Author details
Helena Lenasi*
Address all correspondence to: helena.lenasi.ml@mf.uni-lj.si
Institute of Physiology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
References
[1] O'Farrell FM, Attwell D. A role for pericytes in coronary no-reflow. Nat Rev Cardiol
2014; 11(7):427–432. DOI: 10.1038/nrcardio.2014.58
[2] Pries AR, Badimon L, Bugiardini R, Camici PG, Dorobantu M, Duncker DJ, et al.
Coronary vascular regulation, remodelling, and collateralization: mechanisms and
clinical implications on behalf of the working group on coronary pathophysiology and
microcirculation. Eur Heart J 2015; 36(45):3134–3146. DOI: 10.1093/eurheartj/ehv100
Introductory Chapter: Microcirculation in Health and Disease
http://dx.doi.org/10.5772/64680
9
[3] Deussen A, Ohanyan V, Jannasch A, Yin L, Chilian W. Mechanisms of metabolic
coronary flow regulation. J Mol Cell Cardiol 2012; 52(4):794–801. DOI: 10.1016/j.yjmcc.
2011.10.001
[4] Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update.
Eur Heart J 2014; 35(17):1101–1111.DOI: 10.1093/eurheartj/eht513
[5] van  den  Akker  J,  Schoorl  MJ,  Bakker  EN,  Vanbavel  E.  Small  artery  remodeling:
current  concepts  and  questions.  J  Vasc  Res  2010;  47(3):183–202.  DOI:
10.1159/000255962
[6] Korthuis RJ. Exercise Hyperemia and Regulation of Tissue Oxygenation During
Muscular Activity. Skeletal Muscle Circulation. San Rafael (CA): Morgan and Claypool
Life Sciences, 2011.
[7] Kolka CM, Richey JM, Castro AV, Broussard JL, Ionut V, Bergman RN. Lipid‐induced
insulin resistance does not impair insulin access to skeletal muscle. Am J Physiol
Endocrinol Metab 2015; 308(11):E1001–E1009.
[8] Richey JM,  Ader  M,  Moore  D,  Bergman RN.  Angiotensin  II  induces  insulin
resistance independent of  changes in interstitial  insulin.  Am J Physiol  1999;  277(5
Pt  1):E920–E926.
[9] Karaca U, Schram MT, Houben AJ, Muris DM, Stehouwer CD. Microvascular dysfunc‐
tion as a link between obesity, insulin resistance and hypertension. Diabetes Res Clin
Pract 2014; 103(3):382–387.
[10] Heinonen I, Saltin B, Kemppainen J, Sipila HT, Oikonen V, Nuutila P, et al. Skeletal
muscle blood flow and oxygen uptake at rest and during exercise in humans: a pet
study with nitric oxide and cyclooxygenase inhibition. Am J Physiol Heart Circ Physiol
2011; 300(4):H1510–H1517.
[11] Sjoberg KA, Holst JJ, Rattigan S, Richter EA, Kiens B. GLP‐1 increases microvascular
recruitment but not glucose uptake in human and rat skeletal muscle. Am J Physiol
Endocrinol Metab 2014; 306(4):E355–E362.
[12] Aronis KN, Chamberland JP, Mantzoros CS. GLP‐1 promotes angiogenesis in human
endothelial cells in a dose‐dependent manner, through the Akt, Src and PKC pathways.
Metabolism 2013; 62(9):1279–1286.
[13] Kolka CM, Rattigan S, Richards S, Clark MG. Metabolic and vascular actions of
endothelin‐1 are inhibited by insulin‐mediated vasodilation in perfused rat hindlimb
muscle. Br J Pharmacol 2005; 145(7):992–1000.
[14] Bussey CT, Kolka CM, Rattigan S, Richards SM. Adiponectin opposes endothelin‐1‐
mediated vasoconstriction in the perfused rat hindlimb. Am J Physiol Heart Circ
Physiol 2011; 301(1):H79–H86.
Microcirculation Revisited - From Molecules to Clinical Practice10
[15] Serne EH, Ijzerman RG, Gans RO, Nijveldt R, de Vries G, Evertz R, et al. Direct evidence
for insulin-induced capillary recruitment in skin of healthy subjects during physiolog-
ical hyperinsulinemia. Diabetes 2002; 51(5):1515–1522.
[16] Vincent MA, Clerk LH, Lindner JR, Klibanov AL, Clark MG, Rattigan S, et al. Micro-
vascular recruitment is an early insulin effect that regulates skeletal muscle glucose
uptake in vivo. Diabetes 2004; 53(6):1418–1423.
[17] Becker BF, Chappell D, Bruegger D, Annecke T, Jacob M. Therapeutic strategies
targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res
2010; 87:300–310.
[18] Chen JX, et al. Isoprostanes as physiological mediators of transition to newborn life:
novel mechanisms regulating patency of the term and preterm ductus arteriosus.
Pediatr Res 2012; 72(2):122–128.
[19] Schwepcke A, et al. Microcirculatory mechanisms in postnatal hypotension affecting
premature infants. Pediat Res 2013; 74(2):186–190.
[20] Kent AL, Wright IM, Abdel-Latif ME. Mortality and adverse neurologic outcomes are
greater in preterm male infants. Pediatrics 2012; 129(1):124–131.
[21] Dyson RM, et al. A role for H2S in the microcirculation of newborns: the major
metabolite of H2S (thiosulphate) is increased in preterm infants. PLoS One 2014;
9(8):e105085.
[22] Stark MJ, et al. The influence of sex and antenatal betamethasone exposure on vaso-
constrictors and the preterm microvasculature. J Matern Fetal Neonatal Med 2011;
24(10):1215–1220.
[23] Dyson RM, et al. Interactions of the gasotransmitters contribute to microvascular tone
(dys)regulation in the preterm neonate. PLoS One 2015; 10(3): e0121621.
[24] Knecht KR, et al. Time-dependent action of carbon monoxide on the newborn cerebro-
vascular circulation. Am J Physiol Heart Circ Physiol 2010; 299:H70–H75.
[25] Zinkevich NS, Wittenburg AL, Gutterman DD. Abstract 15764: role of cyclooxygenase
in flow-induced dilation of human coronary arterioles depends upon age. Circulation
2010; 122(Suppl 21):A15764.
[26] Tacconelli S, Patrignani P. Inside epoxyeicosatrienoic acids and cardiovascular disease.
Front Pharmacol 2014; 10(5):239.
[27] Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;
82:47–95.
[28] Boegehold MA, Drenjancevic I, Lombard JH. Salt, angiotensin II, superoxide, and
endothelial function. Compr Physiol 2015; 6(1):215–254.
Introductory Chapter: Microcirculation in Health and Disease
http://dx.doi.org/10.5772/64680
11
[29] Williams B, Baker AQ, Gallacher B, Lodwick D. Angiotensin II increases vascular
permeability factor gene expression by human vascular smooth muscle cells. Hyper‐
tension 1995; 25(5):913–917.
[30] Riedel B, Schier R. Endothelial dysfunction in the perioperative setting. Semin Cardi‐
othorac Vasc Anesth 2010; 14:41–43.
[31] Schier R, El‐Zein R, Cortes A, et al. Endothelial progenitor cell mobilization by
preoperative exercise: a bone marrow response associated with postoperative outcome.
Br J Anaesthesia 2014; 113:652–660
[32] Grueter BE, Schulz UG. Age‐related cerebral white matter disease (leukoaraiosis): a
review. Postgrad Med J 2012; 1036:79–87. DOI: 10.1136/postgradmedj‐2011‐130307.
[33] Zupan M, Šabović M, Zaletel M, et al. The presence of cerebral and/or systemic
endothelial dysfunction in patients with leukoaraiosis – a case control pilot study. BMC
Neurol 2015; 15:158. DOI: 10.1186/s12883‐015‐0416‐z.
[34] Birns J, Jarosz J, Markus HS, et al. Cerebrovascular reactivity and dynamic autoregu‐
lation in ischaemic subcortical white matter disease. J Neurol Neurosurg Psychiat 2009:
80:1093–1098.
[35] Malan L, Hamer, M, Frasure‐Smith N, et al. COHORT PROFILE: Sympathetic activity
and Ambulatory Blood Pressure in Africans (SABPA) Prospective Cohort Study. Int J
Epidemiol 2015;44:1814–1822. DOI:10.1093/ije/dyu199.
[36] Malan L, Hamer M, von Känel R, et al. Chronic depression symptoms and salivary NOx
associated with retinal vascular dysregulation: the SABPA study. Nitric Oxide. DOI:
1016/j.niox.2016.02.008.
[37] Hellhammer DH, Wüst S, Kudielka BM. Salivary cortisol as a marker in stress research.
Psychoneuroendocrinology 2009;34:163–171.
[38] Cavka A, Cosic A, Jukic I, Jelakovic B, Lombard JH, Phillips SA, Seric V, Mihaljevic I,
Drenjancevic I. The role of cyclo‐oxygenase‐1 in high‐salt diet‐induced microvascular
dysfunction in humans. J Physiol 2015; 593(24):5313–5324.
[39] Lal C, Leahy MJ. An Updated Review of Methods and Advancements in Microvascular
Blood Flow Imaging 2016 Microcirculation. Apr 20. DOI: 10.1111/micc.12284. [Epub
ahead of print].
[40] Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsoe CP, et al. Guidelines
and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS)
in the liver – update 2012. Ultrasound Med Biol 2013;34(1):11–29. DOI: 10.1016/
j.ultrasmedbio.2012.09.002.
[41] Heine GH, Gerhart MK, Ulrich C, Kaler H, Girndt M. Renal Doppler resistance indices
are associated with systemic atherosclerosis in kidney transplant recipients. Kidney
Intl 2005; 68(2):878–885. DOI: 10.1111/j.1523‐1755.2005.00470.x.
Microcirculation Revisited - From Molecules to Clinical Practice12
[42] Kupeli A, Kul S, Eyuboglu I, Oguz S, Mungan S. Role of 3D power Doppler ultrasound
in the further characterization of suspicious breast masses. Eur J Radiol 2016; 0(1):1–6.
DOI: 10.1016/j.ejrad.2015.10.019.
[43] Lassau N, Paturel‐Asselin C, Guinebretiere JM, Leclere J, Koscielny S, Roche A, et al.
New hemodynamic approach to angiogenesis: color and pulsed Doppler ultrasonog‐
raphy. Invest Radiol 1999;34(3):194–198. DOI: 10.1097/00004424‐199903000‐00007.
[44] Schmidt WA. Technology insight: the role of color and power Doppler ultrasonography
in rheumatology. Nat Clin Pract Rheum 2007;3(1):35–42. DOI: 10.1038/ncprheum0377.
[45] Noditi G, Todea C. Laser Doppler imaging – as a non‐invasive method for assessing
regional microcirculation when using plastic materials for guided healing. Mater Plast
2013; 1(50):40–43.
[46] Miron MI, Dodenciu D, Calniceanu M, Lungeanu D, Filip LM, Balabuc CA, Todea C.
Evaluation of the effect of ambient light on laser Doppler flowmetry recordings in
anterior teeth. Arch Balkan Medical Union 2009; 44(4):265–270.
[47] Todea C, Canjau S, Dodenciu D, Miron MI, Tudor A, Bălăbuc C. Laser Doppler
flowmetry evaluation of gingival recovery response after laser treatment. Head and
Neck Optical Diagnostics, Proc. SPIE 8805 2013; 880508: DOI: 10.1117/12.2034038.
[48] Tocci  G,  Paneni  F,  Palano  F,  Sciarretta  S,  Ferrucci  A,  Kurtz T,  et  al.  Angiotensin‐
converting  enzyme  inhibitors,  angiotensin  II  receptor  blockers  and  diabetes:  a
meta‐analysis  of  placebo‐controlled  clinical  trials.  Am  J  Hypertens  2011;  24(5):
582–590.
[49] Blondin DP, Labbe SM, Phoenix S, Guerin B, Turcotte EE, Richard D, et al. Contributions
of white and brown adipose tissues and skeletal muscles to acute cold‐induced
metabolic responses in healthy men. J Physiol 2015; 593(3):701–714.
[50] Calabro RS, Gervasi G, Baglieri A, et al. Is high oral dose L‐arginine intake effective in
leukoaraiosis? Preliminary data, study protocol and expert's opinion. Curr Aging Sci
2013; 6(2):170–177.
[51] Luppi P, Powers RW, Verma V, Edmunds L, Plymire D, Hubel CA. Maternal circulating
CD34+VEGFR‐2+ and CD133+VEGFR‐2+ progenitor cells increase during normal
pregnancy but are reduced in women with preeclampsia. Reproduct Sci 2010; 17(7):
643–652.
[52] Rehman J, Li J, Parvathaneni L, et al. Exercise acutely increases circulating endothelial
progenitor cells and monocyte‐/macrophage‐derived angiogenic cells. J Am Coll
Cardiol 2004; 43:2314–2318.
[53] Ott I, Keller U, Knoedler M, Gotze KS, Doss K, Fischer P, et al. Endothelial‐like cells
expanded from CD34+ blood cells improve left ventricular function after experimental
myocardial infarction. FASEB J 2005; 19(8):992–994.
Introductory Chapter: Microcirculation in Health and Disease
http://dx.doi.org/10.5772/64680
13
[54] Alessio AM, Beltrame MP, Nascimento MC, Vicente CP, de Godoy JA, Silva JC, et al.
Circulating progenitor and mature endothelial cells in deep vein thrombosis. Intl J Med
Sci 2013; 10(12):1746–1754.
[55] Ikutomi M, Sahara M, Nakajima T, Minami Y, Morita T, Hirata Y, et al. Diverse contri‐
bution of bone marrow‐derived late‐outgrowth endothelial progenitor cells to vascular
repair under pulmonary arterial hypertension and arterial neointimal formation. J Mol
Cell Cardiol 2015; 86:121–135.
[56] Lara‐Hernandez R, Lozano‐Vilardell P, Blanes P, Torreguitart‐Mirada N, Galmes A,
Besalduch J. Safety and efficacy of therapeutic angiogenesis as a novel treatment in
patients with critical limb ischemia. Ann Vascular Surg 2010; 24(2):287–294.
[57] Gutierrez‐Grobe Y, Gavilanes‐Espinar JG, Masso‐Rojas FA, Sanchez‐Valle V, Paez‐
Arenas A, Ponciano‐Rodriguez G, et al. Metabolic syndrome and nonalcoholic fatty
liver disease. The role of endothelial progenitor cells. Ann Hepatol 2013; 12(6):908–914.
Microcirculation Revisited - From Molecules to Clinical Practice14
